Search Results
5-year survival outcomes from the PACIFIC trial
Looking at the PACIFIC Trial
Post-hoc subgroup analysis from PACIFIC: durvalumab after CRT in unresectable stage III EGFRm NSCLC
Dr. Spigel on the Rationale Behind the PACIFIC Trial
Striking results from the PACIFIC trial
The PACIFIC Trial in Stage 3 NSCLC
Chemotherapy Choices in the PACIFIC Trial
CheckMate 816: what does the data tell us?
Researcher comment: 5-year KEYNOTE-001 results | Edward Garon
Dr. Moghanaki on the Impact of the PACIFIC Trial on NSCLC Treatment
Durvalumab Consolidation in NSCLC: The PACIFIC Trial
New data from the PACIFIC trial for NSCLC
